CLDI
Calidi Biotherapeutics signs lease agreement for office space.
Calidi Biotherapeutics entered a 44-month lease for 9,038 square feet. This agreement outlines rent obligations and terms through 2030.
CLDI news
Latest 3 stories · newest Jul 16, 2026
CLDI
Calidi Names Dr. Corsee Sanders to Board of Directors
Calidi Biotherapeutics has appointed former Genentech and Celgene executive Dr. Corsee Sanders to its board of directors. This addition brings decades of clinical development experience to the team as Calidi advances its proprietary genetic medicine pipeline.
CLDI
Calidi Biotherapeutics amends and restates common stock purchase warrant terms
Calidi Biotherapeutics issued an amended and restated warrant agreement for common stock purchases with modified exercise terms and conditions. The filing reflects standard warrant restructuring typical of biotech equity financing activities.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same CLDI feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CLDI/newsSTART FREE